Synopsis: The FDA granted orphan drug designation to GC012F, a novel chimeric antigen receptor T-cell…
Tag:
Biopharmaceutical
-
-
Ropeginterferon
FDA Approves Ropeginterferon Alfa-2b-njft (Besremi) Treatment for Rare Blood Disease Polycythemia Vera (PV).
by adminSUMMARY: PharmaEssentia Corporation a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven…
-
ChemIntelligence
US – based firm Amneal procure India’s Injectable Maker Punishka Healthcare for Rs 700 crores
by adminAmneal Pharmaceuticals, Inc. on Tuesday announced it has acquired Puniska Healthcare Pvt. Ltd. for a…
-
Global Market
Ardelyx Reports Additive Positive Data Supporting Clinical Utility of Tenapanor at ASN’s Kidney Week 2021
by adminKey Point – First patient reported outcome data on Tenapanor from OPTIMIZE trial demonstrates improved…
-
ChemIntelligence
An Exciting Strategic Collaboration between Dunad Therapeutics and Novartis to Develop Next-generation Oral Targeted Protein Degrader Therapies.
by adminKEYWORDS: Dunad Therapeutics, a biopharmaceutical company focusing on the development of next-generation targeted protein degradation therapies,…
-
ATG-101ChemIntelligence
Antengene Receives FDA Approval of IND for Phase 1 Trial of ATG-101 (PD-L1/4-1BB bispecific antibody) in Solid Tumors and Non-Hodgkin Lymphoma.
by adminKEYPOINTS; Antengene Corporation Limited announced that the US Food and Drug Administration (FDA) has approved…
-
ChemIntelligence
IMPACT Therapeutics Announced ATR Inhibitor IMP9064 IND Clearance by USFDA.
by adminSUMMARY: Impact Therapeutics is a biopharmaceutical company, announced that its ATR inhibitor IMP9064 has received…
-
Active Pharmaceutical Ingredients (API)Ataluren
ANVISA grants expanded Approval to PTC’s Translarna label to include Ambulatory Patients as young as 2 years old in Brazil.
by adminKeypoints: PTC Therapeutics, Inc. announced that the Brazilian National Health Surveillance Agency has approved the…
-
Global Market
Neuland Donepezil Hydrocholoride Becomes the first API to get Certificate of Suitability (CEP)
by adminNeuland announces that The European Directorate for the Quality of Medicines & HealthCare (EDQM) recently granted a…
-
ChinaPharma Science & Research
Green Signal for Kintor Pharma, PD-L1/TGF-β dual-targeting antibody (GT90008) for Tumour Clinical Trail from China NMPA
by adminKintor Pharmaceutical Limited (“Kintor Pharma”, HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological…
Newer Posts